Back to results
US 2009/0214587 A1Published application
Recombinant virus and use thereof
AssigneesPost Genome Institute Co., Ltd., The Chemo-Sero-Therapeutic Research Institute
InventorsMichinori Kohara, Kyosuke Mizuno, Hisatoshi Shida, Kouji Matsushima, Koichi Morita, Minoru Kidokoro, Yukie Sameshima
Life of this patent
Estimating the term…
Abstract
The present invention provides a recombinant virus which is efficacious and highly safe in preventing the onset of SARS infection and a vaccine for SARS coronavirus containing the same. The recombinant virus of the invention can express a SARS coronavirus gene.
Claims9
A recombinant virus capable of expressing Severe Acute Respiratory Syndrome (SARS) coronavirus gene.
Dependencies are inferred from the claim text.